A critical role for neutrophil elastase in experimental bullous pemphigoid

Journal of Clinical Investigation

Volumn 105, Issue 1, 2000, Pages 113-123

  Liu, Zhi ^a   Shapiro, Steven D ^b   Zhou, Xiaoye ^a   Twining, Sally S ^a   Senior, Robert M ^b   Giudice, George J ^a   Fairley, Janet A ^a,c   Diaz, Luis A ^a,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; LEUKOCYTE ELASTASE; LEUKOCYTE ELASTASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVITY; HEMIDESMOSOME; MOUSE; MUTANT; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PEMPHIGOID; PRIORITY JOURNAL;

EID: 0033986322     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3693     Document Type: Article

References (64)

1. Jordon, R.E., et al. 1967. Basement zone antibodies in bullous pemphigoid. JAMA. 200:751-756.
2. Schaumburg-Lever, G., Orfanos, C.E., and Lever, C.E. 1971. Electron microscopic study of bullous pemphigoid. Arch. Dermatol. 106:662-667.
3. Dvorak, A.M., et al. 1982. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies of one parient. J. Invest. Dermatol. 78:91-101.
4. Anhalt, G.F., and Morrison, L. 1993. Pemphigoid: bullous, gestational and cicatricial. In Bullous diseases. T.T. Provost and W.L. Weston, editors. Mosby Year Book. St. Louis, MO. 63-114.
5. Labib, R.S., Anhalt, G.J., Patel, H.P., Mutasim, D.F., and Diaz, L.A. 1986. Molecular heterogeneity of bullous pemphigoid antigens as detected by immunoblotting. J. Immunol. 136:1231-1235.
6. Mutasim, D.F., et al. 1985. A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J. Invest. Dermatol. 84:47-53.
7. Diaz, L.A., et al. 1990. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J. Clin. Invest. 86:1088-1094.
8. Giudice, G.J., Squiquera, H.L., Elias, P.M., and Diaz, L.A. 1991. Identification of two collagen domains within the bullous pemphigoid autoantigen. BP180. J. Clin. Invest. 87:734-738.
9. Giudice, G.J. Emery, D.J., and Diaz, L.A. 1992. Cloning and primary structural analysis of the bullous pemphigoid autoantigen, BP-180. J. Invest. Dermatol. 99:243-250.
10. Hopkinson, S.B., Riddelle, K.S., and Jones, J.C.R. 1992. Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization. J. Invest. Dermatol. 99:264-270.
11. Nishikawa, Y., Uematsu, J., and Owaribe, K. 1993. HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. J. Biochem. 113:493-501.
12. Giudice, G.J., et al. 1993. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J. Immunol. 151:5742-5750.
13. Bedane, C., et al. 1997. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina Iucida. J. Invest. Dermatol. 108:901-907.
14. Hirako, Y., Usukura, J., Nishizawa, Y., and Owaribe, K. 1996. Demonstration of the molecular shape of BP180, a 180-kDa bullous pemphigoid antigen and its potential for trimer formation. J. Biol. Chem. 271:13739-13745.
15. Balding, S.D., Diaz, L.A., and Giudice, G.J. 1997. A recombinant form of the human BP180 ectodomain forms a collagen-like homotrimeric complex. Biochemistry. 36:8821-8830.
16. Zillikens, D., et al. 1997. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J. Invest. Dermatol. 109:573-579.
17. Liu, Z., et al. 1993. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J. Clin. Invest. 92:2480-2488.
18. Liu, Z., et al. 1995. The role of complement in experimental bullous pemphigoid. J. Clin. Invest. 95:1539-1544.
19. Liu, Z., et al. 1997. A major role of neutrophils in experimental bullous pemphigoid. J. Clin. Invest. 100:1256-1263.
20. Jordon, R.E., Kawana, S., and Fritz, K.A. 1985. Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J. Invest. Dermatol. 85(Suppl.):72s-78s.
21. Gammon, W.R. 1989. Immune complex and complement-mediated leukocyte recruitment in bullous pemphigoid. Immunol. Ser. 46:509-525.
22. Weiss, S.J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365-376.
23. Senior, R.M., and Campbell, E.J. 1983. Neutral proteinases from human inflammatory cells. A critical review of their role in extracellular matrix degradation. Clin. Lab. Med. 3:645-666.
24. Janoff, A. 1985. Elastase in tissue injury. Annu. Rev. Med. 36:207-216.
25. Oikarinen, A.I., Zone, J.J., Ahmed, A.R., Kiistala, U., and Uitto, J. 1983. Demonstration of collagenase and elastase activities in blister fluids from bullous skin diseases. Comparison between dermatitis herpetiformis and bullous pemphigoid. J. Invest. Dermatol. 81:261-266.
26. Welgus, H.G., Bauer, E.A., and Stricklin, G.P. 1986. Elevated levels of human collagenase inhibitor in blister fluids of diverse etiology. J. Invest. Dermatol. 87:592-596.
27. Grando, S.A., Glukhenky, B.T., Drannik, G.N., Kostromin, A.P., and Chernyavsky, A.I. 1989. Cytotoxic proteinases in blister fluid of pemphigus and pemphigoid patients. Int. J. Tissue React. 11:195-201.
28. Grando, S.A., et al. 1989. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid. Arch. Dermatol. 125:925-930.
29. Gissler, H.M., Simon, M.M., and Kramer, M.D. 1992. Enhanced association of plasminogen/plasmin with lesional epidermis of bullous pemphigoid. Br. J. Dermatol. 127:272-277.
30. Kramer, M.D., and Reinartz, J. 1993. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/α2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin. J. Clin. Invest. 92:978-983.
31. Ståhle-Bäckdahl, M., Inoue, M., Giudice, G.J., and Parks, W.C. 1994. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J. Clin. Invest. 93:2022-2030.
32. Liu, Z., et al. 1998. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med. 188:475-482.
33. Belaaouaj, A., et al. 1998. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat. Med. 4:615-618.
34. Li, K., Tamai, K., Tan, E.M.L., and Uitto, J. 1993. Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5′-end of ehe gene and the 3′-untranslated region of the mRNA. J. Biol. Chem. 268:8825-8834.
35. Liu, Z., Diaz, L.A., Haas, A.L., and Giudice, G.J. 1992. cDNA cloning of a novel human ubiquitin carrier protein. An antigenic domain specifically recognized by endemic pemphigus foliaceus autoantibodies is encoded in a secondary reading frame of this human epidermal transcript. J. Biol. Chem. 267:15829-15835.
36. Bradley, P.P., Priebat, D.A., Christensen, R.D., and Rothstein, G. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:206-209.
37. Nakajima, K., Powers, J.C., Ashe, B.M., and Zimmerman, M. 1979. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the α1-proteinase inhibitor reactive site. J. Biol. Chem. 254:4027-4032.
38. Barrett, A.J. 1981. Cathepsin G. Methods Enzymol. 80:561-566.
39. Twining, S.S., et al. 1996. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis. Invest. Ophthalmol. Vis. Sci. 37:511-522.
40. Metcalf, J.A., Gallin, J.I., Nauseef, W.M., and Root, R.K. 1985. Laboratory manual of neutrophil function. Raven Press. New York, NY, 2-10.
41. Desrochers, P.E., Mookhtiar, K., Van Wart, H.E., Hasty, K.A., and Weiss, S.J. 1992. Proteolytic inactivation of α1-proteinase inhibitor and α1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases. J. Biol. Chem. 267:5005-5012.
42. Briggaman, R.A., Schechter, N.M., Fraki, J., and Lazarus, G.S. 1984. Degradation of the epidermal-dermal junction by proteolyric enzymes from human skin and human polymorphonuclear leukocytes. J. Exp. Med. 160:1027-1042.
43. Gossage, J.R., Kuratomi, Y., Davidson, J.M., Lefferts, P.L., and Snapper, J.R. 1993. Neutrophil elastase inhibitors, SC-37698 and SC-39026, reduce endotoxin-induced lung dysfunction in awake sheep. Am. Rev. Respir. Dis. 147:1371-1379.
44. Rudolphus, A., Stolk, J., Dijkman, J.H., and Kramps, J.A. 1993. Inhibition of lipopolysaccharide-induced pulmonary emphysema by intratracheally instilled recombinant secretory leukocyte protemase inhibitor. Am. Rev. Resp. Dis. 147:442-447.
45. Gossage, J.R., et al. 1995. Secretory leukoprotease inhibitor attenuates lung injury induced by continuous air embolization into sheep. J. Appl. Physiol. 79:1163-1172.
46. Yoshimura, K., Nakagawa, S., Koyama, S., Kobayashi, T., and Homma, T. 1994. Roles of neutrophil elastase and superoxide anion in leukotriene B4-induced lung injury in rabbit. J. Appl. Physiol. 76:91-96.
47. Vogelmeier, C., Gillissen, A., and Buhl, R. 1996. Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity. Chest. 110(Suppl.):261S-266S.
48. Masunaga, T., et al. 1997. The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane. J. Invest. Dermatol. 109:200-206.
49. McGrath, J.A., et al. 1995. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a transmembrane hemidesmosomal collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat. Genet. 11:83-86.
50. Starkey, P.M. 1977. The effect of human neutrophil elastase and cathepsin G on the collagen of cartilage, tendon, and cornea. Acta Biol. Med. Ger. 36:1549-1554.
51. Gadek, J.E., Fells, G.A., Wright, D.G., and Crystal, R.G. 1980. Human neutrophil elastase functions as a type III collagen "collagenase". Biochem. Biophys. Res. Commun. 95:1815-1822.
52. Mainardi, C.L., Hasty, D.L., Seyer, J.M., and Kang, A.H. 1980. Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J. Biol. Chem. 255:12006-12010.
53. Mainardi, C.L., Dixit, S.N., and Kang, A.H. 1980. Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J. Biol. Chem. 255:5435-5441.
54. McDonald, J.A., and Kelly, D.G. 1980. Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J. Biol. Chem. 255:8848-8858.
55. Malemud, C.J., and Janoff, A. Identification of neutral proteases in human neutrophil granules that degrade articular cartilage proteoglycan. Arthritis Rheum. 18:361-368.
56. Schalkwijk, J., Joosten, L.A.B., van den Berg, W.B., and van den Putte, L.B.A. 1988. Elastase secreted by activated polymorphonuclear leukocytes causes chondrocyte damage and matrix degradation in intact articular cartilage. Agents Actions. 23:58-59.
57. Hautamaki, R.D., Kobayashi, D.K., Senior, R.M., and Shapiro, S.D. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 277:2002-2004.
58. Vu, T.H., and Werb, Z. 1998. Gelatinase B: structure, regulation, and function. In Matrix metalloproteinases. W.C. Parks and R.P. Mecham, editors. Academic Press. San Diego, CA. 115-148.
59. Welgus, H.G., et al. 1990. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 86:1496-1502.
60. Hibbs, M.S., Hasty, K.A., Seyer, J.M., Kang, A.M., and Mainardi, C.L. 1985. Biochemical and immunological characterization of secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260:2493-2500.
61. Senior, R.M., et al. 1991. Human 92-kilodalton and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266:7870-7875
62. Sires, U.I., et al. 1997. Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. J. Biol. Chem. 268:2069-2074.
63. Ackerman, A.B., et al. 1997. Histologic diagnosis of inflammatory skin diseases. 2nd edition. Lippincott, Williams & Wilkins. Baltimore, 238-239.
64. Gammon, W.R., et al. 1982. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J. Invest. Dermatol. 78:285-290.